I'm pretty sure it was one of the people involved in assessing that trial which - in a guardian article you posted on here - said that the longer spacing had provided the better results. They also explained it was an accident it had happened, a happy accident, but an accident nevertheless. But that's what science is, trial and error.
My point is, we have to see how it plays out. Pfizer roll out started mid-December, we have a lot of people who have received full doses - yes it could be more, but that would mean less people have received any protection at all.
The hope has to be that as more and more vaccines get approved and more and more AZ doses become available, that we can start shortening the spacing perhaps? But right now, we just don't know. All we know is infection rates are going down and the vaccine programme is getting doses into arms at speed. 600k today, that is nothing but positive, it just isn't.
Anyway, I'm off to sleep.